AI for Drug Discovery
Nov 06, 2025•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Summary
This episode explores Insitro's innovative approach to drug discovery using AI and machine learning. Ajamete Kaykas details their Clinimel, Celamel, and ChemML platforms, highlighting the critical role of integrating data from the ground up and fostering interdisciplinary teams. The discussion also covers the challenges of balancing public versus proprietary data generation, managing false positives in drug pipelines, and the evolving role of AI as an enabler rather than a replacement for human scientists in the long journey of therapeutic development.Episode description
Will AI usher in a new era of rapid drug discovery? In this episode of JAMA+ AI Conversations, Editor in Chief Roy Perlis interviews Ajamete Kaykas, Chief eXploration Officer at Insitro, a biotech company looking to apply AI to develop new therapeutics. Related Content:
For the best experience, listen in Metacast app for iOS or Android